Take a look at our previous reports:

Q3 Report

2016

View Report

Annual Report

2016

View Report

Q1 Report

2017

View Report

H1 Report

2017

View Report
English | Dutch
Jump to content [AK + s] Jump to navigation [AK + 3]

Q3 Report 2017

  • Twitter
  • LinkedIn

Primary Menu

  • The Galapagos group
    • Letter from the management
    • At a glance
    • Risk factors
    • The Galapagos share
    • Disclaimer and other information
  • Financial statements
    • Consolidated interim financial statements
      • Consolidated statements of income and comprehensive income
      • Consolidated statements of financial position
      • Consolidated cash flow statements
      • Consolidated statements of changes in equity
    • Notes
      • Basis of preparation
      • Details of the unaudited interim results
      • Contingencies and commitments
      • Significant accounting policies
      • Events after the end of the reporting period
      • Approval of interim financial statements
  • Auditor's report
    • Report on the limited review of the consolidated interim financial results

You are here:

  • Home
  • Welcome

Q3 Report 2017

Letter from the management

Overview of our progress in Q3 2017

Read more

Financial highlights

Group revenues

€106.4million

Read more

Cash position

€1,220.1 million

Read more

Notes

Details of the unaudited interim results

Read more
Download Center
Download Center

We are pioneers in exploring biology, finding new modes of action and developing matching novel medicines.

Onno van de Stolpe, CEO
to page top

Service

  • Glossary of terms
  • Downloads
  • Financial calendar
  • Galapagos Corporate Website

Last update: 26 October 2017

Galapagos Q3 Report 2017 (PDF)

Download the entire report as PDF.

Download PDF (1.5 MB)
English | Dutch
  • Downloads
  • Glossary of terms
  • Colophon
  • Contact
  • Sitemap
  • Annual Report 2016
© Copyright 2017 Galapagos NV
nexxar - digital reporting evolved - Online Report